Design and synthesis of simple macrocycles active against vancomycin-resistant Enterococci (VRE)

被引:11
|
作者
Jia, Yanxing
Ma, Nianchun
Liu, Zuosheng
Bois-Choussy, Michele
Gonzalez-Zamora, Eduardo
Malabarba, Adriano
Brunati, Cristina
Zhu, Jieping [1 ]
机构
[1] CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France
[2] Univ Autonoma Metropolitana Iztapalapa, Mexico City 09340, DF, Mexico
[3] Vicuron Pharmaceut, Italy Res Ctr, I-21040 Gerenzano, VA, Italy
关键词
antibiotics; biaryl ether; glycopeptides; macrocycles; SNAr; vancomycin; ALA-D-LAC; GLYCOPEPTIDE ANTIBIOTICS; STRUCTURAL MODIFICATIONS; CYCLOPEPTIDE ALKALOIDS; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; REDUCTIVE HYDROLYSIS; TEICOPLANIN AGLYCON; BINDING; DERIVATIVES;
D O I
10.1002/chem.200600137
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
16-membered meta,para-cyclophanes mimicking the vancomycin binding pocket (D-O-E ring) were designed and synthesized. The structural key features of these biaryl ether containing macrocycles are (1) the presence of P-amino-a-hydroxy acid or alpha,beta-diamino acid as the C-terminal component of the cyclopeptide and (2) the presence of a hydrophobic chain or lipidated aminoglucose at the appropriate position. Cycloetherification by an intramolecular nucleophilic aromatic substitution reaction (SNAr) is used as the key step for the construction of the macrocycle. The atropselectivity of this ring-closure reaction is found to be sensitive to the peptide backbone and chemoselective cyclization (phenol versus primary amine) is achievable. Glycosylation of phenol was realized with freshly prepared 3,4,6-tri-O-acetyl-2-N-lauroyl-2-amino-2-deoxy-alpha-D-glucopyranosyl bromide under phase-transfer conditions. Minimum inhibitory concentrations for all of the derivatives are measured by using a standard microdilution assay, and potent bioactivities against both sensitive and resistant strains are found for some of these compounds (MIC (minimum inhibitory concentration) = 4 mu g mL(-1) against VRE). From these preliminary SAR studies, it was anticipated that both the presence of a hydrophobic substituent and an appropriate structure of the macrocycle were required for this series of compounds to be active against VRE.
引用
收藏
页码:5334 / 5351
页数:18
相关论文
共 50 条
  • [21] Tradescantia pallida, a natural alternative against vancomycin-resistant Enterococci
    Sundar, Ranjitha Dhevi V.
    Arunachalam, Sathiavelu
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2022, 17 (04) : 154 - 156
  • [22] In vitro activity of daptomycin against isolates of vancomycin-resistant enterococci
    Praharaj, Ira
    Sujatha, S.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (04) : 346 - 347
  • [23] VCA agar (bioMerieux) for selective isolation of vancomycin-resistant Enterococci (VRE) from fecal specimens
    Delmas, J
    Robin, F
    Romaszko, JP
    Baraduc, R
    Lesens, O
    Sirot, J
    Bonnet, R
    PATHOLOGIE BIOLOGIE, 2005, 53 (8-9): : 485 - 489
  • [24] Antibacterial activity of α-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics
    Sakagami, Y
    Iinuma, M
    Piyasena, KGN
    Dharmaratne, HRW
    PHYTOMEDICINE, 2005, 12 (03) : 203 - 208
  • [25] In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci
    Pospisilova, Sarka
    Michnova, Hana
    Kauerova, Tereza
    Pauk, Karel
    Kollar, Peter
    Vinsova, Jarmila
    Imramovsky, Ales
    Cizek, Alois
    Jampilek, Josef
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (12) : 2184 - 2188
  • [26] Antibacterial activity of stilbene oligomers against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) and their synergism with antibiotics
    Kinki University, Faculty of Agriculture, 3327-204 Nakamachi, Nara-shi, Nara 631-8505, Japan
    不详
    Biocontrol Sci., 2007, 1 (7-14): : 7 - 14
  • [27] Vancomycin-Resistant Enterococci in a Chinese Hospital
    S. Li
    Z. Zhang
    Z. H. Mi
    Current Microbiology, 2007, 55 : 125 - 127
  • [28] Vancomycin-resistant enterococci in a Chinese hospital
    Li, S.
    Zhang, Z.
    Mi, Z. H.
    CURRENT MICROBIOLOGY, 2007, 55 (02) : 125 - 127
  • [29] Clinical impact of vancomycin-resistant enterococci
    Patel, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 : 13 - 21
  • [30] Evaluation of Vancomycin-Resistant Enterococci (VRE)-Associated Morbidity Following Relaxation of VRE Screening and Isolation Precautions in a Tertiary Care Hospital
    Popiel, Kristin Y.
    Miller, Mark A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (07) : 818 - 825